Polyethylenimine Linear (PEI, MW 40,000): Mechanisms, Evidence, and Best Practices for High-Efficiency DNA Transfection

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely used as a DNA transfection reagent for in vitro applications. Its linear structure enhances DNA condensation, supporting 60–80% transfection efficiency in HEK-293, CHO-K1, and HeLa cells under serum-containing conditions (Li et al., 2025). The product (APExBIO K1029) enables transient gene expression from small (96-well) to large (100 L bioreactor) scales (APExBIO). PEI-mediated uptake occurs via endocytosis, facilitating robust recombinant protein production and functional gene studies. Recent research confirms that the reagent is compatible with workflows involving neuroinflammation and gene regulation analysis (Li et al., 2025).

Biological Rationale

Efficient delivery of genetic material is essential for molecular biology, cell signaling, and functional genomics studies. Polyethylenimine Linear (PEI, MW 40,000) is a synthetic, positively charged polymer optimized for non-viral DNA transfection. Its linear backbone maximizes interaction with negatively charged DNA and cell surface residues, supporting high transfection efficiencies across diverse eukaryotic cells (see detailed protocols). PEI's compatibility with serum allows for physiological culture conditions during transfection, reducing cellular stress and experimental artifacts. Unlike viral vectors, PEI is non-integrating and suitable for transient expression, critical in recombinant protein production and rapid gene function assessments. This article extends prior guidance on PEI MW 40,000 by providing structured evidence and clarifying the mechanistic and practical scope (see previous overview).

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI MW 40,000 operates via electrostatic complexation. The polymer's amine groups (linear configuration) bind the phosphate backbone of DNA, forming condensed, nanoscale, positively charged particles. These complexes interact with anionic cell membrane proteoglycans, triggering endocytosis-mediated uptake. Endosomal acidification leads to the 'proton sponge effect,' promoting endosomal escape and release of the DNA into the cytosol (mechanistic review). This process is efficient in the presence of serum, as the linear form minimizes cytotoxicity compared to branched PEI.

Evidence & Benchmarks

• Polyethylenimine Linear (PEI, MW 40,000) achieves 60–80% transfection efficiency in HEK-293, CHO-K1, and HeLa cells under standard protocols (37°C, 5% CO₂, serum-containing media) (Li et al., 2025).
• DNA condensation by linear PEI occurs at an optimal nitrogen (N) to phosphate (P) ratio of ~10:1 for maximal efficiency and minimal toxicity (APExBIO K1029 product page).
• PEI MW 40,000 is validated for both small-scale (96-well) and large-scale (up to 100 L) transient protein expression, supporting scalable workflows (APExBIO).
• Transfection with PEI MW 40,000 is compatible with functional gene studies, including neuroinflammation models, as demonstrated in astrocyte assays (Li et al., 2025).
• Linear PEI shows reduced cytotoxicity compared to branched PEI at equivalent molar ratios, supporting higher cell viability in extended incubations (protocol comparison).

Applications, Limits & Misconceptions

PEI MW 40,000 is broadly used for:

• Transient gene expression in mammalian cell lines (e.g., HEK-293, HEK293T, CHO-K1, HepG2, HeLa).
• Recombinant protein production for research and preclinical applications.
• Functional genomics, including gene knockdown or overexpression studies.
• Pathway analysis in inflammation and neurobiology (e.g., studies of NOD2 and H3K18 lactylation in astrocytes) (Li et al., 2025).

Compared to previous practical guides, this article clarifies the mechanistic basis and precise application boundaries of PEI MW 40,000, especially for advanced neuroinflammatory and epigenetic workflows.

Common Pitfalls or Misconceptions

• Not suitable for in vivo systemic delivery: PEI MW 40,000 is optimized for in vitro use; systemic administration can cause toxicity.
• Serum compatibility is not universal: While compatible with most serum-containing media, some serum proteins may interfere in primary or sensitive cell types.
• Efficiency varies by cell line and DNA construct: Transfection rates can drop below 60% in hard-to-transfect lines or with large constructs.
• Repeated freeze-thaw cycles degrade reagent: Store at -20°C for long-term use and at 4°C for frequent use to preserve activity (APExBIO).
• Not appropriate for stable integration: PEI does not integrate DNA into the genome; use viral or integrative systems for stable lines.

Workflow Integration & Parameters

Polyethylenimine Linear (PEI, MW 40,000), as supplied by APExBIO (SKU K1029), is provided at 2.5 mg/mL in 4 mL and 8 mL vials. For a typical 6-well plate transfection, 2–4 μg DNA is mixed with 6–12 μL PEI solution in 200 μL of serum-free buffer, incubated for 10–20 minutes at room temperature, and added to cells at 60–80% confluency. Transfection efficiency depends on the N:P ratio, DNA quality, and cell health. The reagent supports scalability from 96-well screens to 100-liter bioreactors for protein production. For frequent use, store PEI at 4°C; avoid repeated freeze-thaw cycles to maintain performance. This article extends prior scenario-driven lab guidance (see troubleshooting tips), offering updated evidence and mechanistic frameworks for integrating PEI MW 40,000 into modern molecular biology workflows.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a gold standard for efficient, serum-compatible DNA transfection in in vitro research. Its robust performance across cell types, scalability, and compatibility with high-content functional genomics and protein production workflows are well documented. Ongoing research, especially in neuroinflammation and gene regulation, continues to expand the reagent's utility (Li et al., 2025). For detailed protocols and troubleshooting, see the APExBIO product page and referenced application guides.